FDA sent warning letters to five companies marketing Delta-8 THC products, several of which also have CBD product lines. In every case, the Agency came down hard on the disease claims being make in connection with the products.

“The FDA is very concerned about the growing popularity of delta-8 THC products being sold online and in stores nationwide. These products often include claims that they treat or alleviate the side effects related to a wide variety of diseases or medical disorders, such as cancer, multiple sclerosis, chronic pain, nausea and anxiety, “Said FDA Principal Deputy Commissioner Janet Woodcock, MD “It is extremely troubling that some of the food products are packaged and labeled in ways that may appeal to children. We will continue to safeguard Americans’ health and safety by monitoring the marketplace and taking action when companies illegally sell products that pose a risk to public health. ”

Disease claims in forefront of letters

Some of the claims cited in the warning letters that were being made by the companies on both Delta-8 THC and CBD products are shown below. The claims appeared both on the companies’ webpages as well as social media accounts.

  • “Delta-8 THC is showing a lot of promise as an antiemetic that can relieve nausea and vomiting in pediatric cancer patients undergoing chemotherapy.”
  • “Delta-8-THC has also been shown to be effective at killing cancer cells, making it doubly effective for cancer patients.”
  • “If a patient is suffering from autoimmune diseases, Delta-8 THC will offer some relief and support. Some of these diseases include lupus, HIV / AIDS, and multiple sclerosis. “
  • “CBD helps relieve pain, inflammation, nausea, and seizures in many cases.”


By admin

Leave a Reply

Your email address will not be published.